# First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients

> **NCT04431219** · PHASE1,PHASE2 · COMPLETED · sponsor: **Xenothera SAS** · enrollment: 10 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **BIOLOGICAL:** LIS1

## Key facts

- **NCT ID:** NCT04431219
- **Lead sponsor:** Xenothera SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-26
- **Primary completion:** 2022-03-28
- **Final completion:** 2022-03-28
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04431219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04431219, "First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04431219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*